Patanjali Coronil Case: The bench noted that the matter is already listed for hearing in the High Court in September, in which case the case is dismissed as withdrawn.
New Delhi. The Supreme Court on Thursday refused to hear a petition challenging the Madras High Court order on the name of Patanjali's drug Coronil. The High Court had stayed the order of the Single Bench in which Patanjali Ayurved Limited was barred from using the trademark 'Coronil'. This order of the High Court was challenged in the apex court.
A bench of Chief Justice SA Bobde, Judge AS Bopanna and Judge V Ramasubramaniam said, "If we stop the use of the name of coronil during an epidemic only on the basis that it has pesticides in its name, it is not good for this product. Will. ''
Refuse to use the word coronil
The bench noted that the matter is already listed for hearing in the High Court in September, in which case the case is dismissed as withdrawn. The Madras High Court bench has stayed the execution of the single judge for two weeks. The single bench forbade Patanjali Ayurveda and Divya Yoga Mandir Trust to use the word coronil for its medicine (tablet) and fined Rs 10 lakh for taking commercial advantage out of fear over Kovid-19.
High court's single bench said this
The judge of a single bench of the High Court, Chennai-based company Arudra Engineering Pvt. Made an interim order on the petition. The company claims that it has owned the Coronil trademark since 1993. According to the company Coronil-212 SPL and Coronil. 92B was registered in 1993 and the trademark has since been renewed. Arudra Engineering manufactures Rasanayan and sanitizer.
The company said, "At the moment, our right to the trademark is valid until 2027." Arudra Engineering said that although the product the company sells is different, the use of the same trademark violates our intellectual property rights. .